In advanced 1L gastric/GEJ cancers1

A NEW DIRECTION AWAITS

FGFR2b is an emerging protein biomarker overexpressed 
in ~ 38%* of advanced gastric/GEJ cancer patients2

References: 1. FPO 2. FPO 3. FPO